Kazia Therapeutics (KZIA) Change in Account Payables (2020 - 2022)
Kazia Therapeutics (KZIA) posted Change in Account Payables of -$401671.6 for Q4 2022, up 10.44% on a QoQ basis from -$448508.9 in Q4 2020.
Kazia Therapeutics (KZIA) has 2 years of Change in Account Payables data on file, last reported at -$401671.6 in Q4 2022.
- In Q4 2022, Change in Account Payables changed N/A year-over-year to -$401671.6; the TTM figure through Dec 2022 stood at -$1.2 million (changed N/A YoY), while the FY2025 annual figure was -$3.2 million, down 144.8% from the prior year.
- Change in Account Payables improved to -$401671.6 in Q4 2022, from -$448508.9 in the prior quarter.
- Across five years, Change in Account Payables topped out at -$401671.6 in Q4 2022 and bottomed at -$448508.9 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -401,671.59 |
| Dec 31, 2022 | -401,671.59 |
| Dec 31, 2020 | -448,508.89 |
| Dec 31, 2020 | -448,508.89 |